Table 3.
Duration (months) of antithrombotic treatment for the index VTE event
n (%) | Overall (N = 600) |
---|---|
Scheduled (intended) duration | |
3 months | 122 (20.3) |
6 months | 267 (44.5) |
9 months | 2 (0.3) |
12 months | 4 (0.7) |
No scheduled stop date | 205 (34.2) |
Actual duration | |
< 3 months | 52 (8.7) |
3–6 months | 285 (47.5) |
> 6 months | 237 (39.5) |
Unknown (loss of follow-up) | 26 (4.3) |
Abbreviations n number of patients with variable ,VTE Venous Thromboembolism